The Waystar Holding Corp. (Nasdaq: WAY) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered tools to help interpret them. Waystar operates as a healthcare payment software and health information services company, and its filings offer detailed insight into its financial condition, capital structure, and significant corporate events.
Investors can review Form 8-K current reports in which Waystar discloses material events such as quarterly earnings announcements, amendments to its credit agreements, and the completion of acquisitions. For example, the company has filed 8-Ks describing results for specific fiscal quarters, the execution of amendments to its First Lien Credit Agreement, and the closing of the acquisition of Iodine Software, including information about consideration paid and related financing arrangements.
Waystar’s filings also address topics such as its status as an emerging growth company, underwritten secondary offerings by selling stockholders, and stockholder and lockup agreements associated with strategic transactions. These documents provide context on ownership dynamics, board composition changes, and registration rights for significant investors.
On this page, Stock Titan surfaces real-time updates from the SEC’s EDGAR system so that new Waystar filings appear promptly. AI-powered summaries help explain the key points of lengthy documents, highlighting items like revenue and earnings disclosures in earnings-related 8-Ks, terms of material definitive agreements, and details of merger and acquisition transactions. Users can quickly understand what each filing covers without reading every page.
In addition to 8-Ks, investors can use this page to locate Waystar’s periodic reports, such as annual reports on Form 10-K and quarterly reports on Form 10-Q, when available, as well as any proxy statements or registration statements referenced in the company’s disclosures. For those tracking governance and ownership, insider transaction reports on Form 4 can also be accessed to monitor equity activity by directors and officers.
By combining structured access to Waystar’s SEC filings with AI-generated explanations, this page is intended to make it easier to analyze complex regulatory documents, follow the company’s financing and M&A activity, and understand the legal and financial context behind its healthcare payment software business.
Waystar Holding Corp. (WAY) reported that Chief Financial Officer Alpana Wegner had 3,409 shares of common stock withheld to pay taxes upon vesting of restricted stock units on October 23, 2026. The shares were valued at $28.76 each, based on the actual sale price in a sell-to-cover transaction. Her reported direct holdings after the transaction were 158,703 shares, including unvested RSUs.
Waystar Holding Corp. (WAY) Chief Executive Officer Matthew J. Hawkins exercised options covering 82,500 shares at an exercise price of $4.14 per share on October 6, 2026, and sold 82,500 common shares at a weighted average $26.2287 per share. The sale prices ranged from $25.98 to $26.60, inclusive.
The common-share acquisition and sale occurred automatically under a Rule 10b5-1 plan adopted March 13, 2026. Following the exercise, Hawkins reported 1,427,598 stock options directly, along with options covering 66,374 shares in a 2024 grantor retained annuity trust and 46,208 shares in a 2025 grantor retained annuity trust.
Waystar Holding Corp. Chief Product & AI Officer William Chan had 9,560 common shares withheld on October 5, 2026, to pay taxes upon vesting of restricted stock units granted October 2, 2025. The reported price was $26.07 per share; the share count was based on the actual sale price in a sell-to-cover transaction. Chan directly held 1,571,252 shares following the transaction, including unvested RSUs.
Waystar Holding Corp. director and officer Matthew Hawkins filed notice to sell 82,500 common shares on October 6, 2026, through Morgan Stanley Smith Barney LLC. The notice lists an aggregate market value of $2,184,600.00. It also lists five earlier sales identified as 10b5-1 sales, dated July 15 through September 2, 2026.
Waystar Holding Corp. (symbol: WAY) is the issuer of record for a Form 4/A filing submitted to the SEC. DRISCOLL JOHN PATRICK reported acquisition or exercise transactions in this Form 4 filing.
Waystar Holding Corp. (WAY) reports that its Director and Chairperson, John Patrick Driscoll, received a grant of 10,446 restricted stock units on June 3, 2026, correcting a previously reported grant of 9,303 units. The units vest on the earlier of June 1, 2027, or the first regularly scheduled annual meeting of stockholders following the grant date. Each unit represents a contingent right to receive one common share upon settlement. Driscoll’s reported direct holdings after the grant were 101,203 shares, including unvested RSUs.
Waystar Holding Corp. (symbol: WAY) is the issuer of record for a Form 4/A filing submitted to the SEC. Gupta Aashima reported acquisition or exercise transactions in this Form 4 filing.
Waystar Holding Corp. director Aashima Gupta received 10,446 restricted stock units (RSUs) on June 3, 2026; the amended report corrects the grant from 9,303 RSUs. The RSUs vest on the earlier of June 1, 2027, and the first regularly scheduled annual meeting of stockholders after the grant date. Each RSU represents a contingent right to receive one share of common stock upon settlement. Gupta’s reported post-transaction holdings were 15,580 shares, including unvested RSUs.
Waystar Holding Corp. (WAY) director Robert DeMichiei acquired 10,446 restricted stock units on June 3, 2026; the amendment corrects the previously reported grant from 9,303 to 10,446 units. His reported direct holdings after the award were 47,342 shares, including unvested RSUs. Each RSU represents a contingent right to receive one share of common stock upon settlement.
Waystar Holding Corp. (symbol: WAY) is the issuer of record for a Form 4/A filing submitted to the SEC. Riefberg Vivian E. reported acquisition or exercise transactions in this Form 4 filing.
Waystar Holding Corp. (WAY) director Vivian E. Riefberg was granted 10,446 restricted stock units (RSUs) on June 3, 2026. The amended report corrects the grant count from 9,303 to 10,446. Her reported direct position after the grant was 24,275 shares, including unvested RSUs. The RSUs vest on the earlier of June 1, 2027, and the first regularly scheduled annual meeting of stockholders following the grant date; each RSU represents a contingent right to receive one Common Stock share upon settlement. No Rule 10b5-1 plan is reported.
Waystar Holding Corp. (symbol: WAY) is the issuer of record for a Form 4/A filing submitted to the SEC. MILLER HEIDI reported acquisition or exercise transactions in this Form 4 filing.
Waystar Holding Corp. (WAY) director Heidi Miller received a grant of 10,446 restricted stock units on June 3, 2026. The amended report corrects the previously reported grant count from 9,303 to 10,446. The units vest on the earlier of June 1, 2027, and the first regularly scheduled annual stockholder meeting after the grant date; each unit represents a contingent right to receive one common share upon settlement. Her reported direct holdings after the award were 42,060 shares, including unvested RSUs. No Rule 10b5-1 plan is reported.
Waystar Holding Corp. (symbol: WAY) is the issuer of record for a Form 4/A filing submitted to the SEC. Roman Michael F reported acquisition or exercise transactions in this Form 4 filing.
Waystar Holding Corp. director Roman Michael F received a direct award of 10,446 restricted stock units on June 3, 2026. The units vest on the earlier of June 1, 2027, or the first regularly scheduled annual meeting of stockholders following the grant date. The reported resulting position was 15,580 shares, including unvested RSUs. The amendment corrects the grant count from 9,303 to 10,446.